Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2007 4
2008 2
2009 2
2010 1
2011 3
2012 5
2013 2
2014 1
2015 2
2017 1
2018 3
2019 3
2020 1
2021 4
2022 1
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL; KEYNOTE-412 Investigators. Machiels JP, et al. Lancet Oncol. 2024 May;25(5):572-587. doi: 10.1016/S1470-2045(24)00100-1. Epub 2024 Mar 29. Lancet Oncol. 2024. PMID: 38561010 Clinical Trial.
Tivantinib (ARQ197) in hepatocellular carcinoma.
Porta C, Giglione P, Ferrari A, Reversi F, Liguigli W, Imarisio I, Ganini C. Porta C, et al. Among authors: imarisio i. Expert Rev Anticancer Ther. 2015 Jun;15(6):615-22. doi: 10.1586/14737140.2015.1050383. Expert Rev Anticancer Ther. 2015. PMID: 26035719 Review.
Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma.
Secondino S, Pedrazzoli P, Basso S, Bossi P, Bianco A, Imarisio I, Pagani A, De Cicco M, Muscianisi S, Casanova M, Morosi C, Bergamini C, Benazzo M, Cossu Rocca M, Perotti C, Baldanti F, Zecca M, Licitra LF, Comoli P. Secondino S, et al. Among authors: imarisio i. Front Immunol. 2023 Jul 11;14:1208475. doi: 10.3389/fimmu.2023.1208475. eCollection 2023. Front Immunol. 2023. PMID: 37497213 Free PMC article.
Electrochemotherapy of superficial tumors - Current status:: Basic principles, operating procedures, shared indications, and emerging applications.
Campana LG, Miklavčič D, Bertino G, Marconato R, Valpione S, Imarisio I, Dieci MV, Granziera E, Cemazar M, Alaibac M, Sersa G. Campana LG, et al. Among authors: imarisio i. Semin Oncol. 2019 Apr;46(2):173-191. doi: 10.1053/j.seminoncol.2019.04.002. Epub 2019 May 9. Semin Oncol. 2019. PMID: 31122761 Review.
Meningeal melanomatosis: a challenge for timely diagnosis.
Berzero G, Diamanti L, Di Stefano AL, Bini P, Franciotta D, Imarisio I, Pedrazzoli P, Magrassi L, Morbini P, Farina LM, Bastianello S, Ceroni M, Marchioni E. Berzero G, et al. Among authors: imarisio i. Biomed Res Int. 2015;2015:948497. doi: 10.1155/2015/948497. Epub 2015 Jan 14. Biomed Res Int. 2015. PMID: 25648721 Free PMC article.
Sorafenib rechalenge in metastatic renal cell carcinoma.
Porta C, Paglino C, Imarisio I. Porta C, et al. Among authors: imarisio i. BJU Int. 2012 Sep;110(6 Pt B):E235. doi: 10.1111/j.1464-410X.2011.10920.x. Epub 2012 Feb 14. BJU Int. 2012. PMID: 22332769 No abstract available.
34 results